Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Dunger

Showing results (111-120 of 237) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|July 6, 1985
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogueD B Dunger, M J Dillon, C Daman-Willems, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Increased overnight growth hormone concentrations in diabetic compared with normal adolescentsJ A Edge, D B Dunger, D R Matthews, et al.
Diabetologia|March 29, 2001
Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetesC J Schultz, R N Dalton, H A Neil, et al.
BMJ (Clinical Research Ed.)|February 7, 2001
Association between postnatal catch-up growth and obesity in childhood: prospective cohort studyK K Ong, M L Ahmed, P M Emmett, et al.
Diabetes Care|April 6, 2001
Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study GroupC J Schultz, H A Neil, R N Dalton, et al.
Diabetologia|January 1, 1994
Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study GroupJ H Pinkey, P J Bingley, P A Sawtell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 28, 2009
Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuriaM L Marcovecchio, C Giannini, R N Dalton, et al.
Diabetes Care|May 20, 1998
Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone ageM L Ahmed, M H Connors, N M Drayer, et al.
Lancet (London, England)|July 4, 1998
Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitusC L Acerini, C M Patton, M O Savage, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1992
Sex hormone binding globulin levels in adolescent subjects with diabetes mellitusJ M Holly, D B Dunger, S A al-Othman, et al.
Pageof 24

Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|July 6, 1985
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogueD B Dunger, M J Dillon, C Daman-Willems, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Increased overnight growth hormone concentrations in diabetic compared with normal adolescentsJ A Edge, D B Dunger, D R Matthews, et al.
Diabetologia|March 29, 2001
Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetesC J Schultz, R N Dalton, H A Neil, et al.
BMJ (Clinical Research Ed.)|February 7, 2001
Association between postnatal catch-up growth and obesity in childhood: prospective cohort studyK K Ong, M L Ahmed, P M Emmett, et al.
Diabetes Care|April 6, 2001
Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study GroupC J Schultz, H A Neil, R N Dalton, et al.
Diabetologia|January 1, 1994
Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study GroupJ H Pinkey, P J Bingley, P A Sawtell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 28, 2009
Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuriaM L Marcovecchio, C Giannini, R N Dalton, et al.
Diabetes Care|May 20, 1998
Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone ageM L Ahmed, M H Connors, N M Drayer, et al.
Lancet (London, England)|July 4, 1998
Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitusC L Acerini, C M Patton, M O Savage, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1992
Sex hormone binding globulin levels in adolescent subjects with diabetes mellitusJ M Holly, D B Dunger, S A al-Othman, et al.
Pageof 24